ZA882061B - Mixtures for treating hypercholesterolemia - Google Patents

Mixtures for treating hypercholesterolemia

Info

Publication number
ZA882061B
ZA882061B ZA882061A ZA882061A ZA882061B ZA 882061 B ZA882061 B ZA 882061B ZA 882061 A ZA882061 A ZA 882061A ZA 882061 A ZA882061 A ZA 882061A ZA 882061 B ZA882061 B ZA 882061B
Authority
ZA
South Africa
Prior art keywords
mixtures
treating hypercholesterolemia
hypercholesterolemia
treating
administered orally
Prior art date
Application number
ZA882061A
Other languages
English (en)
Inventor
David Broaddus Charles
Original Assignee
The Procter And Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter And Gamble Company filed Critical The Procter And Gamble Company
Publication of ZA882061B publication Critical patent/ZA882061B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA882061A 1987-03-24 1988-03-23 Mixtures for treating hypercholesterolemia ZA882061B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/029,825 US4849222A (en) 1987-03-24 1987-03-24 Mixtures for treating hypercholesterolemia

Publications (1)

Publication Number Publication Date
ZA882061B true ZA882061B (en) 1988-09-14

Family

ID=21851092

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882061A ZA882061B (en) 1987-03-24 1988-03-23 Mixtures for treating hypercholesterolemia

Country Status (14)

Country Link
US (1) US4849222A (fr)
EP (1) EP0285201B1 (fr)
JP (1) JP2581737B2 (fr)
KR (1) KR970004956B1 (fr)
AT (1) ATE79544T1 (fr)
AU (1) AU620541B2 (fr)
CA (1) CA1314230C (fr)
DE (1) DE3873800T2 (fr)
DK (1) DK167847B1 (fr)
IE (1) IE61404B1 (fr)
IL (1) IL85689A (fr)
NZ (1) NZ223947A (fr)
PH (1) PH26694A (fr)
ZA (1) ZA882061B (fr)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579752A (en) * 1984-10-29 1986-04-01 At&T Bell Laboratories Enhanced corrosion resistance of metal surfaces
JPH0788318B2 (ja) * 1986-08-06 1995-09-27 三菱レイヨン株式会社 イソブチレンの製造法
US5095008A (en) * 1987-09-14 1992-03-10 The Procter & Gamble Company Cookies containing psyllium
US4950140A (en) * 1987-09-14 1990-08-21 The Procter & Gamble Company Cookies containing psyllium
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
US4978529A (en) * 1988-05-25 1990-12-18 Denick Jr John Easily dispersible psyllium compositions
US5149541A (en) * 1988-10-03 1992-09-22 The Procter & Gamble Company Psyllium-containing produces with a distribution of particle size
US5024996A (en) * 1989-12-05 1991-06-18 General Mills, Inc. R-T-E cereal with soluble fibers
US5026689A (en) * 1989-03-29 1991-06-25 General Mills, Inc. R-T-E cereal with psyllium
US5219570A (en) * 1989-08-10 1993-06-15 The Procter & Gamble Company Agglomerated psyllium husk containing edible acid
US6419911B1 (en) 1993-09-17 2002-07-16 Board Of Trustees Of Michigan State University Psyllium containing snack bars, processes for making these, and uses thereof
US5126150A (en) * 1990-10-01 1992-06-30 The Procter & Gamble Company Compositions containing psyllium
AU663693B2 (en) * 1990-12-20 1995-10-19 Procter & Gamble Company, The Psyllium and cholestyramine compositions with improved palatability
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
WO1993013801A1 (fr) * 1992-01-17 1993-07-22 The Procter & Gamble Company Traitement de l'arteriosclerose
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5258181A (en) * 1992-03-02 1993-11-02 The Procter & Gamble Company Compositions containing psyllium
NZ249745A (en) * 1992-03-11 1996-10-28 Procter & Gamble Psyllium drink mix having granulated base
WO1993018756A1 (fr) * 1992-03-20 1993-09-30 The Procter & Gamble Company Compositions de resine exchangeuse d'ions
US5232698A (en) * 1992-06-12 1993-08-03 The Proctor & Gamble Company Psyllium drink mix compositions
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5338549A (en) * 1992-12-21 1994-08-16 The Procter & Gamble Company Powdered psyllium drink mix compositions containing antioxidant
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US5384136A (en) * 1993-09-17 1995-01-24 Kellogg Company Psyllium-enriched dough products and method for making the same
US5382443A (en) * 1993-09-17 1995-01-17 Kellogg Company Ready-to-eat cereals containing extruded pre-wetted psyllium
US5384144A (en) * 1993-09-17 1995-01-24 Kellogg Company Psyllium enriched pasta products and method for making same
US5955123A (en) * 1996-10-21 1999-09-21 The Procter & Gamble Company Baked compositions comprising psyllium
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
CA2310231A1 (fr) 1997-11-07 1999-05-27 Kellogg Company Substances intermediaires extrudees et contenant une fibre soluble, et produit contenant ces substances
US6123978A (en) 1998-08-31 2000-09-26 Mcneil-Ppc, Inc. Stable salad dressings
US6248387B1 (en) 1998-11-05 2001-06-19 Kellogg Company Psyllium enriched baked snack foods
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7238380B2 (en) * 2000-02-22 2007-07-03 Suzanne Jaffe Stillman Water containing soluble fiber
AU2003274353B2 (en) 2002-10-24 2007-04-05 Merz Pharma Gmbh & Co. Kgaa Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
MXPA05012493A (es) * 2003-05-27 2006-05-25 Forest Laboratories Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo.
JP2004352626A (ja) * 2003-05-28 2004-12-16 Asahi Breweries Ltd 植物由来成分を含有する抗コレステロール剤
US20050113458A1 (en) * 2003-10-22 2005-05-26 Forest Laboratories, Inc. Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathies
TW200616608A (en) * 2004-07-09 2006-06-01 Forest Laboratories Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
CA2578953A1 (fr) * 2004-09-23 2006-03-30 Merz Pharma Gmbh & Co. Kgaa Memantine pour le traitement des troubles du comportement de l'enfant
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
KR100679290B1 (ko) * 2005-06-30 2007-02-05 박정휘 Ｈｇｄ­ｓｊ­201 생약 복합제 추출물을 포함하는 비만의예방 및 치료용 조성물
WO2007005898A2 (fr) * 2005-07-05 2007-01-11 Cornell Research Foundation, Inc. Blocage de l'emigration des leucocytes et de l'inflammation par le blocage de cd99l2
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ATE532507T1 (de) 2007-09-12 2011-11-15 Merz Pharma Gmbh & Co Kgaa Neramexane zur behandlung von subakuten tinnitus
EP2085120A1 (fr) 2008-02-01 2009-08-05 Merz Pharma GmbH & Co. KGaA Utilisation de substances pour le traitement d'une déficience de récepteur d'insuline périphérique ou central et résistance à l'insuline
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
CA2737335C (fr) 2008-12-19 2013-10-01 Merz Pharma Gmbh & Co. Kgaa Derives de 1-amino-alkylcyclohexane dans le traitement de maladies mediees par des mastocytes
TWI432188B (zh) 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
WO2011000564A1 (fr) 2009-06-30 2011-01-06 Merz Pharma Gmbh & Co. Kgaa Eltoprazine pour le traitement de la pharmacodépendance
WO2011000562A1 (fr) 2009-06-30 2011-01-06 Merz Pharma Gmbh & Co. Kgaa Eltoprazine pour le traitement de certains troubles du mouvement
US20120190690A1 (en) 2009-06-30 2012-07-26 Merz Pharma Gmbh & Co. Kgaa Eltoprazine for the treatment of weight disorders
US20120136005A1 (en) 2009-06-30 2012-05-31 Merz Pharma Gmbh & Co. Kgaa Eltoprazine for the treatment of anxiety
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (fr) 2010-04-12 2011-10-20 Academia Sinica Puces au glycane pour la recherche par criblage haut débit de virus
US20110294890A1 (en) 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
WO2012023033A2 (fr) 2010-08-18 2012-02-23 Purdue Pharma L.P. Immunogènes peptidiques améliorés
JP6084931B2 (ja) 2011-01-20 2017-02-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ストレス又は急性聴力損失に関連する耳鳴の治療又は予防のためのネラメキサン
WO2012171653A1 (fr) 2011-06-15 2012-12-20 Merz Pharma Gmbh & Co. Kgaa Sarizotan pour une utilisation dans le traitement d'un trouble d'hyperactivité avec déficit de l'attention (thada)
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
TW201412325A (zh) 2012-06-20 2014-04-01 梅茲製藥有限兩合公司 用於治療患有青光眼及其他退化性眼疾之人類視力喪失的間隔醫療
WO2014031498A1 (fr) 2012-08-18 2014-02-27 Academia Sinica Sondes perméables aux cellules pour l'identification et l'imagerie de sialidases
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (fr) 2013-06-27 2014-12-31 Academia Sinica Conjugués de glycane et leur utilisation
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
RU2666141C2 (ru) 2013-09-17 2018-09-06 Оби Фарма, Инк. Композиции углеводной вакцины для индукции иммунного ответа и их применение при лечении рака
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
EP3129767B1 (fr) 2014-03-27 2021-09-01 Academia Sinica Composés de marquage réactifs et leurs utilisations
DK3149045T3 (da) 2014-05-27 2023-03-06 Academia Sinica Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗ＴＮＦα糖操作抗体群およびその使用
EP3191500A4 (fr) 2014-09-08 2018-04-11 Academia Sinica Activation des cellules inkt humaines par des glycolipides
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10342858B2 (en) 2015-01-24 2019-07-09 Academia Sinica Glycan conjugates and methods of use thereof
JP2018532990A (ja) 2015-09-04 2018-11-08 オービーアイ ファーマ，インコーポレイテッド グリカンアレイおよび使用の方法
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
US10980894B2 (en) 2016-03-29 2021-04-20 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
US11041017B2 (en) 2016-03-29 2021-06-22 Obi Pharma, Inc. Antibodies, pharmaceutical compositions and methods
KR20250048399A (ko) 2016-04-22 2025-04-08 오비아이 파머 인코퍼레이티드 글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에 의한 암 면역요법
WO2018022933A1 (fr) 2016-07-27 2018-02-01 Obi Pharma, Inc. Compositions de glycanes immunogènes/thérapeutiques et utilisations associées
EP3491026A4 (fr) 2016-07-29 2020-07-29 OBI Pharma, Inc. Anticorps humains, compositions pharmaceutiques et procédés
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use
JP2019535731A (ja) 2016-11-21 2019-12-12 オービーアイ ファーマ，インコーポレイテッド コンジュゲートさせた生物学的分子、医薬組成物及び方法
US11203645B2 (en) 2018-06-27 2021-12-21 Obi Pharma, Inc. Glycosynthase variants for glycoprotein engineering and methods of use
EP3791873A1 (fr) 2019-09-16 2021-03-17 Universite De Bordeaux Procédés de traitement et/ou de prévention de troubles et de symptômes associés aux channelophathies bkca et/ou sk

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831854A (en) * 1955-05-24 1958-04-22 Procter & Gamble Method for preparing fatty esters of non-reducing oligosaccharides in the presence of an amide
US3455714A (en) * 1964-09-01 1969-07-15 Hercules Inc Cellulose derivatives of improved dispersibility and process
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions
US3579548A (en) * 1968-05-10 1971-05-18 Procter & Gamble Triglyceride esters of alpha-branched carboxylic acids
US3954976A (en) * 1973-12-14 1976-05-04 The Procter & Gamble Company Pharmaceutical compositions for inhibiting absorption of cholesterol
US3963699A (en) * 1974-01-10 1976-06-15 The Procter & Gamble Company Synthesis of higher polyol fatty acid polyesters
US4034083A (en) * 1975-11-03 1977-07-05 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005196A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
IE44458B1 (en) * 1976-02-12 1981-12-02 Procter & Gamble Compositions for treating hypercholesterolemia
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4241054A (en) * 1978-12-08 1980-12-23 The Procter & Gamble Company Detoxifying lipophilic toxins
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
US4382924A (en) * 1980-06-25 1983-05-10 The Procter & Gamble Company Palatable composition containing oil or oil-like materials
DE3027611A1 (de) * 1980-07-21 1982-02-18 Bayer Ag, 5090 Leverkusen Di- und oligo-1,2,4-triazolidin-3,5-dione und verfahren zu ihrer herstellung
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4461782A (en) * 1982-02-16 1984-07-24 The Procter & Gamble Company Low calorie baked products
US4518772A (en) * 1983-06-23 1985-05-21 The Proctor & Gamble Company Synthesis of higher polyol fatty acid polyesters using high soap:polyol ratios
US4517360A (en) * 1983-06-23 1985-05-14 The Procter & Gamble Company Synthesis of higher polyol fatty acid polyesters using carbonate catalysts

Also Published As

Publication number Publication date
PH26694A (en) 1992-09-15
US4849222A (en) 1989-07-18
DK167847B1 (da) 1993-12-27
IE61404B1 (en) 1994-11-02
CA1314230C (fr) 1993-03-09
DK162488D0 (da) 1988-03-24
IE880870L (en) 1988-09-24
KR880010764A (ko) 1988-10-24
EP0285201B1 (fr) 1992-08-19
DE3873800D1 (de) 1992-09-24
KR970004956B1 (ko) 1997-04-10
ATE79544T1 (de) 1992-09-15
AU620541B2 (en) 1992-02-20
JPS6426A (en) 1989-01-05
EP0285201A3 (en) 1990-01-24
DK162488A (da) 1988-09-25
DE3873800T2 (de) 1993-01-14
EP0285201A2 (fr) 1988-10-05
JP2581737B2 (ja) 1997-02-12
AU1352188A (en) 1988-09-22
IL85689A (en) 1993-05-13
NZ223947A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
EP0285201A3 (en) Mixtures for treating hypercholesterolemia
DE3876054D1 (de) Psyllium enthaltende kuchen.
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
FI900052A7 (fi) Koostumuksia ja hoitomenetelmiä peräpukamia ja muita varten
GR3007092T3 (fr)
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
HUT57993A (en) Process for producing pharmaceutical composition comprising combination of an active ingredient lowering cholesterol level and of ace inhibitor, suitable for treating arteriosclerosis
AU7061687A (en) Pharmaceutical composition for treating periodontal diseases
GB8708481D0 (en) Tissue disintegrator
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
AU5287090A (en) Method and composition for treatment of periodontal disease
HUT59944A (en) Process for producing polymeres for controlling blood cholesterol level and pharmaceutical compositions containing them
GB2202442B (en) Treatment of periodontal disease
IE883878L (en) Mixed compositions for treating hypercholesterolemia
AU6857887A (en) Therapeutic agent
AU1279788A (en) Compounds and treatment
EP0313654A4 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie.
AU5185790A (en) Treatment of tibial dyschondroplasia
AU1621788A (en) Pharmacologically active cholinergic compositions, and methods for making same and use thereof in treating disease
GB2206341B (en) Treatment of organically-based waste matter
GB8714972D0 (en) Medical treatment
EP0286802A3 (fr) Emploi de l'ofloxacine pour le traitement ou la prophylaxie topique des troubles péridontiques
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
AU588790B3 (en) Treatment of waste